• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people
Basel, 28 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys ® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers³ have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks⁴ (cTnT-hs) and bett er manage heart failure⁵ (NT-proBNP). Roche ' s introduction of five new intended uses for these existing, globally accepted diagnostic solutions means more people could benef...
Source: Roche Media News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Clinical Use of Wearable Technology
While privacy concerns, accuracy of data collected, and FDA approval are all concerns in wearable technology, interest in clinical use of the devices has already begun. Some devices in use include: Compact electrocardiogram monitor. According to the American Heart Association, cardiovascular disease and stroke are the two cause of death in American adults. Cardiovascular monitoring is vital to diagnosis and treatment of heart disease, and remote patient monitoring assists with this effort. Wristband to monitor epileptic seizures. A device which can detect seizures in patients who have epilepsy can be used to record the tim...
Source: Dragonfly - July 26, 2017 Category: Databases & Libraries Authors: Patricia Devine Tags: Data Technology Source Type: news